Clinical Trial Update: Special Investigation For Patients With Renal And/Or Hepatic Disorders On Aromasin

View source ↗

Summary

This clinical trial update reports results from a special safety investigation of exemestane (Aromasin) in patients with renal and/or hepatic impairment; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms

Drugs mentioned

• Aromasin (exemestane)

Snippet

Sponsor: Pfizer | Conditions: Breast Neoplasms | Status: COMPLETED | Results posted: 2010-06-24